Omicron-targeted vaccine may not make much difference

+News

Omicron-targeted vaccine may not make much difference

Natasha
Jojoa Burling
MMR vaccines
Pfizer plans to submit data to Medsafe on variant vaccines over the coming months
“There is little gain in buying an Omicron-strain specific vaccine because it’s the first Omicron variant and now is dominated by type 5” Te What